| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I transforming growth factor beta receptor binding | 1.76e-05 | 13 | 10 | 2 | GO:0034713 | |
| GeneOntologyMolecularFunction | activin receptor binding | 2.05e-05 | 14 | 10 | 2 | GO:0070697 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 3.06e-05 | 17 | 10 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 7.87e-05 | 27 | 10 | 2 | GO:0070696 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 1.04e-04 | 31 | 10 | 2 | GO:0005160 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 1.33e-04 | 35 | 10 | 2 | GO:0033612 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.41e-04 | 36 | 10 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | SMAD binding | 8.07e-04 | 86 | 10 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | phospholipid binding | 2.14e-03 | 548 | 10 | 3 | GO:0005543 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.18e-03 | 749 | 10 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.08e-02 | 324 | 10 | 2 | GO:0005126 | |
| GeneOntologyMolecularFunction | lipid binding | 1.12e-02 | 988 | 10 | 3 | GO:0008289 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 1.17e-02 | 337 | 10 | 2 | GO:0031625 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.31e-02 | 358 | 10 | 2 | GO:0044389 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 7.60e-06 | 9 | 10 | 2 | GO:0033292 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 4.42e-05 | 21 | 10 | 2 | GO:0032926 | |
| GeneOntologyBiologicalProcess | glycerol metabolic process | 4.86e-05 | 22 | 10 | 2 | GO:0006071 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 5.81e-05 | 24 | 10 | 2 | GO:0010801 | |
| GeneOntologyBiologicalProcess | alditol metabolic process | 6.83e-05 | 26 | 10 | 2 | GO:0019400 | |
| GeneOntologyBiologicalProcess | regulation of activin receptor signaling pathway | 1.04e-04 | 32 | 10 | 2 | GO:0032925 | |
| GeneOntologyBiologicalProcess | plasma membrane repair | 1.18e-04 | 34 | 10 | 2 | GO:0001778 | |
| GeneOntologyBiologicalProcess | negative regulation of SMAD protein signal transduction | 1.55e-04 | 39 | 10 | 2 | GO:0060392 | |
| GeneOntologyBiologicalProcess | muscle cell development | 2.20e-04 | 259 | 10 | 3 | GO:0055001 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 2.56e-04 | 50 | 10 | 2 | GO:0030279 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 2.77e-04 | 52 | 10 | 2 | GO:0010799 | |
| GeneOntologyBiologicalProcess | activin receptor signaling pathway | 3.69e-04 | 60 | 10 | 2 | GO:0032924 | |
| GeneOntologyBiologicalProcess | muscle structure development | 5.11e-04 | 858 | 10 | 4 | GO:0061061 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 6.55e-04 | 80 | 10 | 2 | GO:0030514 | |
| GeneOntologyBiologicalProcess | negative regulation of protein ubiquitination | 7.74e-04 | 87 | 10 | 2 | GO:0031397 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 8.10e-04 | 89 | 10 | 2 | GO:0060411 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 8.28e-04 | 90 | 10 | 2 | GO:0060390 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 8.47e-04 | 91 | 10 | 2 | GO:0003281 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.55e-04 | 412 | 10 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification by small protein conjugation or removal | 1.02e-03 | 100 | 10 | 2 | GO:1903321 | |
| GeneOntologyBiologicalProcess | negative regulation of post-translational protein modification | 1.10e-03 | 104 | 10 | 2 | GO:1901874 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.17e-03 | 107 | 10 | 2 | GO:0001657 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 1.23e-03 | 110 | 10 | 2 | GO:0060395 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.23e-03 | 110 | 10 | 2 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.23e-03 | 110 | 10 | 2 | GO:0072163 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.30e-03 | 113 | 10 | 2 | GO:0001823 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 1.35e-03 | 115 | 10 | 2 | GO:0018107 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 1.42e-03 | 118 | 10 | 2 | GO:0046928 | |
| GeneOntologyBiologicalProcess | polyol metabolic process | 1.54e-03 | 123 | 10 | 2 | GO:0019751 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.59e-03 | 125 | 10 | 2 | GO:0018210 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 1.60e-03 | 512 | 10 | 3 | GO:0031400 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.74e-03 | 131 | 10 | 2 | GO:0030510 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 1.78e-03 | 531 | 10 | 3 | GO:0042692 | |
| GeneOntologyBiologicalProcess | artery development | 1.80e-03 | 133 | 10 | 2 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.82e-03 | 134 | 10 | 2 | GO:0003279 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.93e-03 | 138 | 10 | 2 | GO:0030512 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.01e-03 | 141 | 10 | 2 | GO:0051588 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 2.19e-03 | 147 | 10 | 2 | GO:0030278 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 2.28e-03 | 150 | 10 | 2 | GO:0090288 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.62e-03 | 161 | 10 | 2 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 2.62e-03 | 161 | 10 | 2 | GO:0003231 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 2.65e-03 | 162 | 10 | 2 | GO:0072073 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.68e-03 | 163 | 10 | 2 | GO:0002456 | |
| GeneOntologyBiologicalProcess | blood circulation | 3.14e-03 | 648 | 10 | 3 | GO:0008015 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 3.54e-03 | 188 | 10 | 2 | GO:0007009 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 3.69e-03 | 192 | 10 | 2 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 3.81e-03 | 195 | 10 | 2 | GO:1903844 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 3.81e-03 | 195 | 10 | 2 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 3.81e-03 | 195 | 10 | 2 | GO:0007269 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.88e-03 | 197 | 10 | 2 | GO:0030509 | |
| GeneOntologyBiologicalProcess | membrane fusion | 4.44e-03 | 211 | 10 | 2 | GO:0061025 | |
| GeneOntologyBiologicalProcess | circulatory system process | 4.45e-03 | 733 | 10 | 3 | GO:0003013 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.48e-03 | 212 | 10 | 2 | GO:0003205 | |
| GeneOntologyBiologicalProcess | response to BMP | 4.61e-03 | 215 | 10 | 2 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 4.61e-03 | 215 | 10 | 2 | GO:0071773 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.73e-03 | 218 | 10 | 2 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of protein ubiquitination | 5.08e-03 | 226 | 10 | 2 | GO:0031396 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | 5.59e-03 | 795 | 10 | 3 | GO:1902532 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 6.03e-03 | 817 | 10 | 3 | GO:0048514 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 5.76e-06 | 8 | 10 | 2 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 9.25e-06 | 10 | 10 | 2 | GO:0071141 | |
| GeneOntologyCellularComponent | centriolar satellite | 1.62e-03 | 128 | 10 | 2 | GO:0034451 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 3.14e-03 | 179 | 10 | 2 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 3.14e-03 | 179 | 10 | 2 | GO:0030672 | |
| GeneOntologyCellularComponent | centrosome | 4.92e-03 | 770 | 10 | 3 | GO:0005813 | |
| GeneOntologyCellularComponent | lamellipodium | 5.12e-03 | 230 | 10 | 2 | GO:0030027 | |
| MousePheno | skeletal muscle fiber degeneration | 9.60e-05 | 21 | 10 | 2 | MP:0009412 | |
| MousePheno | skeletal muscle degeneration | 1.98e-04 | 30 | 10 | 2 | MP:0009415 | |
| MousePheno | transposition of great arteries | 4.89e-04 | 47 | 10 | 2 | MP:0004110 | |
| MousePheno | muscle degeneration | 6.70e-04 | 55 | 10 | 2 | MP:0000749 | |
| Domain | FerA | 7.74e-07 | 3 | 10 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 7.74e-07 | 3 | 10 | 2 | IPR012560 | |
| Domain | FerA | 7.74e-07 | 3 | 10 | 2 | PF08165 | |
| Domain | Peroxin/Ferlin | 1.55e-06 | 4 | 10 | 2 | IPR006614 | |
| Domain | DysFC | 1.55e-06 | 4 | 10 | 2 | SM00694 | |
| Domain | DysFN | 1.55e-06 | 4 | 10 | 2 | SM00693 | |
| Domain | FerI | 2.58e-06 | 5 | 10 | 2 | SM01202 | |
| Domain | FerB | 2.58e-06 | 5 | 10 | 2 | SM01201 | |
| Domain | FerIin_dom | 2.58e-06 | 5 | 10 | 2 | IPR012968 | |
| Domain | Ferlin_B-domain | 2.58e-06 | 5 | 10 | 2 | IPR012561 | |
| Domain | FerI | 2.58e-06 | 5 | 10 | 2 | PF08151 | |
| Domain | FerB | 2.58e-06 | 5 | 10 | 2 | PF08150 | |
| Domain | Ferlin_C | 2.58e-06 | 5 | 10 | 2 | PF16165 | |
| Domain | Ferlin_C | 2.58e-06 | 5 | 10 | 2 | IPR032362 | |
| Domain | Dwarfin | 7.21e-06 | 8 | 10 | 2 | IPR013790 | |
| Domain | - | 7.21e-06 | 8 | 10 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 7.21e-06 | 8 | 10 | 2 | IPR013019 | |
| Domain | MH2 | 7.21e-06 | 8 | 10 | 2 | PS51076 | |
| Domain | MH1 | 7.21e-06 | 8 | 10 | 2 | PS51075 | |
| Domain | MH2 | 7.21e-06 | 8 | 10 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 7.21e-06 | 8 | 10 | 2 | IPR001132 | |
| Domain | DWB | 7.21e-06 | 8 | 10 | 2 | SM00524 | |
| Domain | MH1 | 1.70e-05 | 12 | 10 | 2 | PF03165 | |
| Domain | MAD_homology1_Dwarfin-type | 1.70e-05 | 12 | 10 | 2 | IPR003619 | |
| Domain | DWA | 1.70e-05 | 12 | 10 | 2 | SM00523 | |
| Domain | SMAD_dom-like | 3.08e-05 | 16 | 10 | 2 | IPR017855 | |
| Domain | - | 3.08e-05 | 16 | 10 | 2 | 2.60.200.10 | |
| Domain | SMAD_FHA_domain | 3.37e-04 | 52 | 10 | 2 | IPR008984 | |
| Domain | C2 | 2.12e-03 | 131 | 10 | 2 | PF00168 | |
| Domain | C2 | 2.31e-03 | 137 | 10 | 2 | SM00239 | |
| Domain | C2 | 2.48e-03 | 142 | 10 | 2 | PS50004 | |
| Domain | - | 2.69e-03 | 148 | 10 | 2 | 2.60.40.150 | |
| Domain | C2_dom | 3.29e-03 | 164 | 10 | 2 | IPR000008 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.30e-04 | 31 | 8 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.30e-04 | 31 | 8 | 2 | MM14789 | |
| Pathway | PID_BMP_PATHWAY | 2.40e-04 | 42 | 8 | 2 | M181 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 3.83e-04 | 53 | 8 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 4.12e-04 | 55 | 8 | 2 | M39351 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.74e-04 | 59 | 8 | 2 | M39886 | |
| Pathway | WP_APOPTOSIS | 9.37e-04 | 83 | 8 | 2 | MM15972 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.01e-03 | 86 | 8 | 2 | M2642 | |
| Pathway | WP_APOPTOSIS | 1.05e-03 | 88 | 8 | 2 | M39654 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 1.64e-03 | 110 | 8 | 2 | MM16642 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 1.82e-03 | 116 | 8 | 2 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 1.85e-03 | 117 | 8 | 2 | M39530 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.88e-03 | 118 | 8 | 2 | MM15588 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.47e-03 | 161 | 8 | 2 | M27871 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 15736400 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 20807502 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 18495154 | ||
| Pubmed | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. | 7.44e-08 | 2 | 10 | 2 | 11959863 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 31004665 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 25550343 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 15033458 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 34354129 | ||
| Pubmed | A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. | 7.44e-08 | 2 | 10 | 2 | 17934461 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 19228595 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 20658468 | ||
| Pubmed | Inhibitory smads and tgf-Beta signaling in glomerular cells. | 2.23e-07 | 3 | 10 | 2 | 12397035 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 30026467 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 12118366 | ||
| Pubmed | Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. | 2.23e-07 | 3 | 10 | 2 | 17931948 | |
| Pubmed | Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. | 2.23e-07 | 3 | 10 | 2 | 18445023 | |
| Pubmed | Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. | 2.23e-07 | 3 | 10 | 2 | 24177035 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 33938174 | ||
| Pubmed | The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers. | 2.23e-07 | 3 | 10 | 2 | 23859474 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 37434585 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 15529348 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 20514018 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 17185750 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 9335505 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 12407115 | ||
| Pubmed | Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7. | 4.46e-07 | 4 | 10 | 2 | 11737269 | |
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 11231077 | ||
| Pubmed | FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. | 7.44e-07 | 5 | 10 | 2 | 16720724 | |
| Pubmed | Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. | 7.44e-07 | 5 | 10 | 2 | 11483516 | |
| Pubmed | Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. | 7.44e-07 | 5 | 10 | 2 | 15817471 | |
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 24687993 | ||
| Pubmed | 1.12e-06 | 6 | 10 | 2 | 18644788 | ||
| Pubmed | Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6. | 1.12e-06 | 6 | 10 | 2 | 23455153 | |
| Pubmed | 1.12e-06 | 6 | 10 | 2 | 9256479 | ||
| Pubmed | SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. | 1.12e-06 | 6 | 10 | 2 | 18069690 | |
| Pubmed | Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload. | 1.12e-06 | 6 | 10 | 2 | 22960056 | |
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 12815042 | ||
| Pubmed | STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. | 1.56e-06 | 7 | 10 | 2 | 10757800 | |
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 10376010 | ||
| Pubmed | Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. | 1.56e-06 | 7 | 10 | 2 | 14657019 | |
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 10647776 | ||
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 11278251 | ||
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 20663871 | ||
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 10708949 | ||
| Pubmed | The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. | 2.08e-06 | 8 | 10 | 2 | 15359284 | |
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 9759503 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 26555259 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 19018011 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 10708948 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 15496141 | ||
| Pubmed | Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. | 2.68e-06 | 9 | 10 | 2 | 16601693 | |
| Pubmed | 3.34e-06 | 10 | 10 | 2 | 15221015 | ||
| Pubmed | 3.34e-06 | 10 | 10 | 2 | 23620745 | ||
| Pubmed | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. | 3.34e-06 | 10 | 10 | 2 | 9436979 | |
| Pubmed | 3.34e-06 | 10 | 10 | 2 | 16890162 | ||
| Pubmed | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. | 4.09e-06 | 11 | 10 | 2 | 19758997 | |
| Pubmed | 4.90e-06 | 12 | 10 | 2 | 14656760 | ||
| Pubmed | TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs. | 5.79e-06 | 13 | 10 | 2 | 18095342 | |
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 11854453 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 12149478 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 21791611 | ||
| Pubmed | 6.76e-06 | 14 | 10 | 2 | 26952187 | ||
| Pubmed | The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. | 8.91e-06 | 16 | 10 | 2 | 21907140 | |
| Pubmed | 1.14e-05 | 18 | 10 | 2 | 19717565 | ||
| Pubmed | Rnf165/Ark2C enhances BMP-Smad signaling to mediate motor axon extension. | 1.56e-05 | 21 | 10 | 2 | 23610558 | |
| Pubmed | USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. | 1.71e-05 | 22 | 10 | 2 | 24850914 | |
| Pubmed | 1.88e-05 | 23 | 10 | 2 | 15621726 | ||
| Pubmed | 2.80e-05 | 28 | 10 | 2 | 26884322 | ||
| Pubmed | 3.01e-05 | 29 | 10 | 2 | 34822715 | ||
| Pubmed | 3.22e-05 | 30 | 10 | 2 | 20534673 | ||
| Pubmed | 4.40e-05 | 35 | 10 | 2 | 18832392 | ||
| Interaction | BAMBI interactions | 2.32e-05 | 15 | 10 | 2 | int:BAMBI | |
| Interaction | RIPOR2 interactions | 2.32e-05 | 15 | 10 | 2 | int:RIPOR2 | |
| Interaction | PIAS4 interactions | 7.14e-05 | 173 | 10 | 3 | int:PIAS4 | |
| Interaction | SMAD6 interactions | 3.36e-04 | 56 | 10 | 2 | int:SMAD6 | |
| GeneFamily | Ferlin family | 4.13e-06 | 6 | 10 | 2 | 828 | |
| GeneFamily | SMAD family | 7.70e-06 | 8 | 10 | 2 | 750 | |
| Coexpression | GAUTSCHI_SRC_SIGNALING | 3.66e-06 | 8 | 10 | 2 | M14722 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP | 5.05e-05 | 200 | 10 | 3 | M4545 | |
| Coexpression | HALMOS_CEBPA_TARGETS_DN | 1.29e-04 | 45 | 10 | 2 | M8604 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 1.46e-04 | 286 | 10 | 3 | M45746 | |
| Coexpression | HALLMARK_TGF_BETA_SIGNALING | 1.85e-04 | 54 | 10 | 2 | M5896 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 174 | 10 | 3 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 174 | 10 | 3 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 182 | 10 | 3 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.55e-06 | 196 | 10 | 3 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-06 | 197 | 10 | 3 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-06 | 198 | 10 | 3 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-06 | 198 | 10 | 3 | f88198e11e835ad53d339c312f8f7b7b0b5c02d3 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 1.01e-05 | 200 | 10 | 3 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 73 | 10 | 2 | cc89c94a3768b02036757dea86989d9284b214b9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 73 | 10 | 2 | ae80fcf3544c18fe0318a8311e96f2448f7cb03c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 73 | 10 | 2 | 6f28d52700bab981c8a3664ba4762f3572f7e788 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tmem163_Arhgap25|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-04 | 117 | 10 | 2 | e1a14b8413a6f4b194217a90eb2c5f95ab14522e | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.90e-04 | 134 | 10 | 2 | 8ba1f8d0af63bb7a802a002e72fe181b203cb451 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.08e-04 | 137 | 10 | 2 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.26e-04 | 140 | 10 | 2 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-04 | 151 | 10 | 2 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 158 | 10 | 2 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-04 | 159 | 10 | 2 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.55e-04 | 160 | 10 | 2 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-04 | 160 | 10 | 2 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-04 | 160 | 10 | 2 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.69e-04 | 162 | 10 | 2 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.76e-04 | 163 | 10 | 2 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.83e-04 | 164 | 10 | 2 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-04 | 166 | 10 | 2 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-04 | 166 | 10 | 2 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-04 | 168 | 10 | 2 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-04 | 169 | 10 | 2 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 170 | 10 | 2 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 170 | 10 | 2 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-04 | 171 | 10 | 2 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.41e-04 | 172 | 10 | 2 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-04 | 172 | 10 | 2 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-04 | 172 | 10 | 2 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.48e-04 | 173 | 10 | 2 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 173 | 10 | 2 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 173 | 10 | 2 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 175 | 10 | 2 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 92ebcea9b2b22601234b76d7a98f0410b905a87b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.71e-04 | 176 | 10 | 2 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 9ddf87e586d2378984cd007c60f7dc254845f8f3 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | e987e741fcf1bed8598a5060700efd3018f8123b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-04 | 176 | 10 | 2 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-04 | 176 | 10 | 2 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-04 | 177 | 10 | 2 | 34458f1eb7f3b1fd0cb9904529c01a9ca2f15500 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-04 | 177 | 10 | 2 | 3a94ee9b58ebdbbc75e00954cf1f6922f88f8f88 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-04 | 177 | 10 | 2 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 6.78e-04 | 177 | 10 | 2 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-04 | 178 | 10 | 2 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-04 | 178 | 10 | 2 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | droplet-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | 006f2b6887b0f1f26e58bb11c919468b62bf4d62 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-04 | 179 | 10 | 2 | 223f0895da89c7606f637aef113912dd06f39c5a | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-04 | 180 | 10 | 2 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-04 | 180 | 10 | 2 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-04 | 180 | 10 | 2 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-04 | 180 | 10 | 2 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-04 | 180 | 10 | 2 | cb6b11883f42c8beff07f899036c803d786ac6a3 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-04 | 180 | 10 | 2 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-04 | 181 | 10 | 2 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.09e-04 | 181 | 10 | 2 | 2c660fcf0404c155955b67ab2958d6e6b0e30024 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-04 | 181 | 10 | 2 | 51836cdc66e42f04ed6a3c167cd6a3a67428c9f7 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 7.09e-04 | 181 | 10 | 2 | 727344d7b2953568b7b3463398c7d56878cf2c2b | |
| ToppCell | Monocytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.09e-04 | 181 | 10 | 2 | d8b98c3d9bef026a0a35948219027f27718ffbee | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-04 | 182 | 10 | 2 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 182 | 10 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 182 | 10 | 2 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | facs-Heart-RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 182 | 10 | 2 | 8292e8e8474c930ffb88cbab4f6ebdb6f58db645 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-04 | 182 | 10 | 2 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.25e-04 | 183 | 10 | 2 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 10 | 2 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 10 | 2 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-04 | 184 | 10 | 2 | df2d42e1eae29fa0a1ed9e389c95b38952b46892 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-04 | 184 | 10 | 2 | 1ace70f12b417185bdd46042833f72b3b6815966 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-04 | 184 | 10 | 2 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-04 | 184 | 10 | 2 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Immature_B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.33e-04 | 184 | 10 | 2 | e6669a1b7ea7e4f8e094add5117689470019d85d | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.41e-04 | 185 | 10 | 2 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.41e-04 | 185 | 10 | 2 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | droplet-Lung-nan-21m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | 43b7345a61e31099718c9cecf194b4e9884b904b | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 7.41e-04 | 185 | 10 | 2 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | droplet-Lung-21m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.41e-04 | 185 | 10 | 2 | 9c907298166e3dd65b1d1e7673a1b8d01b492bd0 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 7.48e-04 | 186 | 10 | 2 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.48e-04 | 186 | 10 | 2 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-04 | 186 | 10 | 2 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.56e-04 | 187 | 10 | 2 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-04 | 187 | 10 | 2 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.56e-04 | 187 | 10 | 2 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 7.56e-04 | 187 | 10 | 2 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.56e-04 | 187 | 10 | 2 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| Drug | pasireotide | 2.65e-05 | 18 | 10 | 2 | ctd:C517782 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 6.27e-05 | 187 | 10 | 3 | 2729_DN | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 6.37e-05 | 188 | 10 | 3 | 6187_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.47e-05 | 189 | 10 | 3 | 1006_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.47e-05 | 189 | 10 | 3 | 1005_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.10e-05 | 195 | 10 | 3 | 999_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 7.21e-05 | 196 | 10 | 3 | 3571_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.21e-05 | 196 | 10 | 3 | 7400_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 7.54e-05 | 199 | 10 | 3 | 2310_DN | |
| Drug | CK2 inhibitor 2 | 1.09e-04 | 36 | 10 | 2 | CID005326976 | |
| Drug | MDPC | 1.28e-04 | 39 | 10 | 2 | CID000032842 | |
| Drug | Iron Compounds | 1.28e-04 | 39 | 10 | 2 | ctd:D058085 | |
| Drug | Octreotide | 1.48e-04 | 42 | 10 | 2 | ctd:D015282 | |
| Drug | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea | 1.94e-04 | 48 | 10 | 2 | ctd:C581572 | |
| Drug | 3 tp | 3.67e-04 | 66 | 10 | 2 | CID009549240 | |
| Drug | galangin | 3.89e-04 | 68 | 10 | 2 | ctd:C037032 | |
| Drug | Bmps | 4.01e-04 | 69 | 10 | 2 | CID004620597 | |
| Drug | 1,3,2-dioxaborolan-2-ol | 9.08e-04 | 104 | 10 | 2 | CID005289333 | |
| Drug | AC1L9Q5W | 9.43e-04 | 106 | 10 | 2 | CID000452221 | |
| Drug | NSC350854 | 9.79e-04 | 108 | 10 | 2 | CID000434448 | |
| Drug | AC1L1K15 | 1.21e-03 | 120 | 10 | 2 | CID000005293 | |
| Drug | Evans blue dye | 1.35e-03 | 127 | 10 | 2 | CID005356750 | |
| Drug | halofuginone | 1.35e-03 | 127 | 10 | 2 | ctd:C010176 | |
| Drug | Asbestos, Crocidolite | 1.42e-03 | 1241 | 10 | 4 | ctd:D017638 | |
| Drug | methyl ethyl ketone | 1.79e-03 | 587 | 10 | 3 | CID000006569 | |
| Drug | MW 1 | 1.90e-03 | 151 | 10 | 2 | CID000073965 | |
| Drug | CP094 | 2.26e-03 | 165 | 10 | 2 | CID000086322 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.45e-03 | 172 | 10 | 2 | 5903_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.45e-03 | 172 | 10 | 2 | 7073_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.48e-03 | 173 | 10 | 2 | 5950_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.48e-03 | 173 | 10 | 2 | 4458_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.51e-03 | 174 | 10 | 2 | 5945_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.51e-03 | 174 | 10 | 2 | 1659_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; HL60; HT_HG-U133A | 2.51e-03 | 174 | 10 | 2 | 3037_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.54e-03 | 175 | 10 | 2 | 6891_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.54e-03 | 175 | 10 | 2 | 5935_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.57e-03 | 176 | 10 | 2 | 5976_DN | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 2.57e-03 | 176 | 10 | 2 | 1345_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.60e-03 | 177 | 10 | 2 | 6434_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.60e-03 | 177 | 10 | 2 | 6551_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.62e-03 | 178 | 10 | 2 | 4710_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.68e-03 | 180 | 10 | 2 | 5981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.71e-03 | 181 | 10 | 2 | 7077_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.74e-03 | 182 | 10 | 2 | 947_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.83e-03 | 185 | 10 | 2 | 3536_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.83e-03 | 185 | 10 | 2 | 5585_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.86e-03 | 186 | 10 | 2 | 916_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.86e-03 | 186 | 10 | 2 | 6874_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.89e-03 | 187 | 10 | 2 | 1631_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.92e-03 | 188 | 10 | 2 | 7091_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 6954_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 5578_DN | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 7392_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 1643_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.98e-03 | 190 | 10 | 2 | 836_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.98e-03 | 190 | 10 | 2 | 5586_DN | |
| Drug | CID11987713 | 2.98e-03 | 190 | 10 | 2 | CID011987713 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.01e-03 | 191 | 10 | 2 | 998_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 4168_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A | 3.01e-03 | 191 | 10 | 2 | 1417_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 3890_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 7165_UP | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 2678_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 5222_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 6353_UP | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 3.04e-03 | 192 | 10 | 2 | 970_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.04e-03 | 192 | 10 | 2 | 993_DN | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 3197_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 7364_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 1644_DN | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 4623_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6811_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6243_DN | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 3.11e-03 | 194 | 10 | 2 | 828_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 5914_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6878_UP | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3504_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6330_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4412_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 2621_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4396_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.14e-03 | 195 | 10 | 2 | 953_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3834_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5269_DN | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 7448_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6172_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5070_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6082_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6310_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5241_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 7034_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 1686_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.17e-03 | 196 | 10 | 2 | 1024_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2051_DN | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 2.17e-06 | 7 | 10 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | nephritis (biomarker_via_orthology) | 5.68e-06 | 11 | 10 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.22e-04 | 80 | 10 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | colorectal cancer, colorectal adenoma | 1.15e-03 | 152 | 10 | 2 | EFO_0005406, MONDO_0005575 | |
| Disease | hippocampal volume | 4.31e-03 | 297 | 10 | 2 | EFO_0005035 | |
| Disease | peak expiratory flow | 1.17e-02 | 498 | 10 | 2 | EFO_0009718 | |
| Disease | eosinophil count | 1.18e-02 | 1488 | 10 | 3 | EFO_0004842 | |
| Disease | retinal vasculature measurement | 1.26e-02 | 517 | 10 | 2 | EFO_0010554 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMILYTRRRWCKRRR | 171 | O14525 | |
| QRRERERRTRKWSRS | 921 | Q99590 | |
| TDAFRRRRWRRRMEP | 1086 | O75923 | |
| RRYVARLEMRRRCTW | 31 | O14830 | |
| QRTMWRRRARSRRAP | 46 | O00198 | |
| MFRSKRSGLVRRLWR | 1 | O43541 | |
| MFRTKRSALVRRLWR | 1 | O15105 | |
| RKTFRWRSNFTRHMR | 631 | P59923 | |
| RRLRAIYTIMRWFRR | 731 | B0I1T2 | |
| RSSDTFRRRRWRRKM | 1066 | Q9NZM1 | |
| FRRRRWRRKMAPSET | 1071 | Q9NZM1 |